Moderate alcohol consumption is more cardioprotective in men with the metabolic syndrome

The aim of the present study was to evaluate the relation among alcohol consumption, the metabolic syndrome, and the risk of ischemic heart disease (IHD). The study was conducted in a cohort of 1966 men from the Quebec Cardiovascular Study. All men were initially free of HID and, during the follow-up period of 13 y, 219 first cases of IHD were diagnosed. Alcohol consumption was determined by calculating the g/d intake based on standard portions of beer, wine, and spirits. Metabolic syndrome was diagnosed according to a modification of the National Cholesterol Education Program Adult Treatment Panel III definition. Men who consumed >= 5.2 g of alcohol/d (4th quartile of the distribution) were younger (P < 0,001), had elevated plasma HDL-C concentrations (P < 0.001), and lower plasma concentrations of insulin (P= 0.01), CRP (P = 0.01), and fibrinogen (P < 0.001) than men in the 1 st quartile (< 1.3 g of alcohol/d). After adjustment for a series of coronary risk factors, alcohol consumption >= 15.2 g/d was associated with a 39% reduction in the 13-y risk of IHD [relative risk (RR) of IHD = 0.61, P= 0.02]. Finally, an alcohol consumption < 15.2 g/d was associated with an increase of the risk of IHD in men with the metabolic syndrome (FIR = 2.24, P < 0.001) but not in m en without the metabolic syndrome (RR = 1.31, P = 0.22). These results confirm that moderate daily alcohol consumption has cardioprotective properties and suggest that the effects may be more important in subjects with a deteriorated risk profile, such as those with the metabolic syndrome.